 9 | |
| |
|
Strict Inclusion/Exclusion criteria were followed, and they were essentially the same ones used in numerous FDA studies of new drugs for symptomatic BPH. | |
This page is being served from the Urological Sciences Research Foundation web repository, and was originally posted between 1996-2008. In January 2009 USRF’s founder, Dr. Leonard S. Marks and his staff joined UCLA’s Department of Urology where they are continuing their research. Click for more information.
|
9 | |
|
| |
|
Strict Inclusion/Exclusion criteria were followed, and they were essentially the same ones used in numerous FDA studies of new drugs for symptomatic BPH. | |